- AU$217.65m
- AU$200.61m
- NZ$103.85m
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million
Aroa Biosurgery eyes annual results at top end of forecast, shares rise
Australia's GreenX Metals rises as Singapore court rejects Poland's set-aside bid
ASX-listed Aroa Biosurgery rises to 3-month high on upbeat FY results, outlook
Brief: Aroa Biosurgery Posts FY Product Revenue NZD 84 Million
Brief: Aroa Biosurgery Expects Net Impact Of New Us Import Tariffs To Be Substantially Lower Than 10%
Australian healthcare stocks rise as Bell Potter sees most cos unfazed by potential tariffs
Brief: Aroa Biosurgery Sees FY25 Total Revenue NZ$81-84 Mln
Australia's Aroa Biosurgery eyes worst day ever on lowering FY25 forecasts
ASX-listed Aroa Biosurgery rises as H1 loss narrows, upbeat H2 outlook
Brief: Aroa Biosurgery Anticipates H2 FY25 Total Revenue Of NZ$43-$50 Million
Brief: Aroa Biosurgery Posts H1 Product Revenue NZ$39.1 Million
ASX-listed Aroa Biosurgery hits over 10-week high on FY outlook
Brief: Aroa Biosurgery Maintains FY25 Revenue Guidance At NZ$80-87 Million
Brief: Aroa Biosurgery Maintains FY25 Normalised EBITDA Profit Guidance
Brief: Aroa Biosurgery Sees FY25 Total Revenue Of NZ$80-87 Million